These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. Rosenfeld S; Follmann D; Nunez O; Young NS JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583 [TBL] [Abstract][Full Text] [Related]
23. Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): an initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC). Williams DA; Bennett C; Bertuch A; Bessler M; Coates T; Corey S; Dror Y; Huang J; Lipton J; Olson TS; Reiss UM; Rogers ZR; Sieff C; Vlachos A; Walkovich K; Wang W; Shimamura A Pediatr Blood Cancer; 2014 May; 61(5):869-74. PubMed ID: 24285674 [TBL] [Abstract][Full Text] [Related]
24. [Evaluation of a prospective therapeutic protocol in adult patients with nonsevere aplastic anemia in South Tunisia]. Bellaaj H; Kallel C; Elloumi M; Rekik H; Kassar O; Hdiji S; Medhaffar M; Souissi T Rev Med Interne; 2008 Dec; 29(12):981-5. PubMed ID: 18502543 [TBL] [Abstract][Full Text] [Related]
25. [The development of immune-mediated aplastic anemia in mice can be blocked by cimetidine]. Wang M; Liao J; Zhao X; Lin C; Jiang Z; Ma X Zhonghua Xue Ye Xue Za Zhi; 2000 Oct; 21(10):527-9. PubMed ID: 11877031 [TBL] [Abstract][Full Text] [Related]
26. Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia. Chandra J; Naithani R; Ravi R; Singh V; Narayan S; Sharma S; Pemde H; Dutta AK Indian J Pediatr; 2008 Mar; 75(3):229-33. PubMed ID: 18376089 [TBL] [Abstract][Full Text] [Related]
27. [Expression of HLA-DRB1*15 genotype in children with acquired aplastic anemia and its relation to effect of immunosuppressive therapy]. Huang YL; Huang SL; Huang K; Bao R Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1212-5. PubMed ID: 18088469 [TBL] [Abstract][Full Text] [Related]
28. Aplastic anemia associated with parenteral chloramphenicol: review of 10 cases, including the second case of possible increased risk with cimetidine. West BC; DeVault GA; Clement JC; Williams DM Rev Infect Dis; 1988; 10(5):1048-51. PubMed ID: 3055188 [TBL] [Abstract][Full Text] [Related]
29. Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome. Kadia TM; Borthakur G; Garcia-Manero G; Faderl S; Jabbour E; Estrov Z; York S; Huang X; Pierce S; Brandt M; Koller C; Kantarjian HM; Ravandi F Br J Haematol; 2012 May; 157(3):312-20. PubMed ID: 22360602 [TBL] [Abstract][Full Text] [Related]
30. Hepatitis-associated aplastic anemia. Brown KE; Tisdale J; Barrett AJ; Dunbar CE; Young NS N Engl J Med; 1997 Apr; 336(15):1059-64. PubMed ID: 9091802 [TBL] [Abstract][Full Text] [Related]
31. Clinical course of non-severe aplastic anemia in adults. Kwon JH; Kim I; Lee YG; Koh Y; Park HC; Song EY; Kim HK; Yoon SS; Lee DS; Park SS; Shin HY; Park S; Park MH; Ahn HS; Kim BK Int J Hematol; 2010 Jun; 91(5):770-5. PubMed ID: 20524094 [TBL] [Abstract][Full Text] [Related]
32. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus. Musuamba FT; Rousseau A; Bosmans JL; Senessael JJ; Cumps J; Marquet P; Wallemacq P; Verbeeck RK Clin Pharmacokinet; 2009; 48(11):745-58. PubMed ID: 19817503 [TBL] [Abstract][Full Text] [Related]
33. [Immunosuppressive therapy for aplastic anemia--review]. Xu CY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):348-52. PubMed ID: 15854308 [TBL] [Abstract][Full Text] [Related]
34. Immunosuppressive therapy in adults with aplastic anaemia: single-institution experience from India. Nair V; Sharma A; Das S; Sondhi V; Sharma S Postgrad Med J; 2013 Sep; 89(1055):508-15. PubMed ID: 23686628 [TBL] [Abstract][Full Text] [Related]
35. Low dose cyclosporine-a therapy in severe aplastic anaemia. Rai M; Singh VP; Shukla J; Sundar S; Jha VC J Assoc Physicians India; 2001 Oct; 49():966-9. PubMed ID: 11848327 [TBL] [Abstract][Full Text] [Related]
36. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine. Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C; Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038 [TBL] [Abstract][Full Text] [Related]
37. Granulocyte colony-stimulating factor (G-CSF) dependent hematopoiesis with monosomy 7 in a patient with severe aplastic anemia after ATG/CsA/G-CSF combined therapy. Nishimura M; Yamada T; Andoh T; Tao T; Emoto M; Ohji T; Matsuda K; Kameda N; Satoh Y; Matsutani A; Azuno Y; Oka Y Int J Hematol; 1998 Aug; 68(2):203-11. PubMed ID: 9803678 [TBL] [Abstract][Full Text] [Related]
38. Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporine. Fang JP; Xu HG; Huang SL; Chen C; Huang K Pediatr Hematol Oncol; 2006; 23(1):45-50. PubMed ID: 16326412 [TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetics and initial dosing regimen optimization of cyclosporin in pediatric hemophagocytic lymphohistiocytosis patients. Wang DD; Ye QF; Chen X; Xu H; Li ZP Xenobiotica; 2020 Apr; 50(4):435-441. PubMed ID: 31382792 [TBL] [Abstract][Full Text] [Related]
40. Modelling ciclosporin double-peak absorption profiles in the early post-transplantation period. Rousseau A; Marquet P Clin Pharmacokinet; 2004; 43(14):1055-7. PubMed ID: 15530133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]